Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

0001411690

Bionano develops and offers optical genome mapping (OGM) solutions. Their Stratys™ and Saphyr™ systems, along with VIA™ software, enable the discovery of structural variants in the genome. Bionano positions itself as an innovator in genomics, focusing on improving health through advanced technology.

87
Erittäin Luotettava
Trust Score

Official Registry

Virallinen Nimi
Bionano Genomics, Inc.
Y-tunnus
0001411690
VAT Number
261756290
Company Status
Active
Address
9540 TOWNE CENTRE DRIVE, SAN DIEGO, CA 92121
Industry Codes
3826: Laboratory Analytical Instruments

Last verified: 1/2/2026

AI Quality Analysis

Industry
Biotechnology
SSL/HTTPS
Secure
Ammattimainen sähköposti
Kyllä
Yhteystiedot sähköposti
support@bionano.com

Trust Score Breakdown

Registry Verified35/35
Quality Score52/60
News Sentiment0/5
Last updated: 1/2/2026

🌟 Vastaavat luotettavat yritykset

Context Therapeutics Inc.

Context Therapeutics Inc. logo
86/100 · Erittäin Luotettava

Context Therapeutics is dedicated to advancing the treatment of solid tumors through the development of next-generation T cell engaging (TCE) bispecific antibody therapies. Their innovative pipeline features clinical-stage bispecific therapeutics designed to harness the immune system for targeted cancer eradication. The company focuses on innovative immunotherapeutic solutions, transforming cancer care and improving outcomes for patients.

2001 MARKET STREET, USA
Näytä profiili

AGENUS INC

AGENUS INC logo
86/100 · Erittäin Luotettava

Agenus is a biotechnology company focused on developing and commercializing immuno-oncology therapies. Their key products include botensilimab and balstilimab, which are in clinical trials for various cancers. The company is positioned as an innovator in the development of next-generation immunotherapies.

3 FORBES ROAD, USA
Näytä profiili

Evaxion A/S

Evaxion A/S logo
77/100 · Luotettava

Evaxion utilizes its AI-Immunology™ platform to challenge and improve standardized treatments. In oncology, they create personalized therapies, tailoring treatment to the individual. For infectious diseases, they design next-generation vaccines to address unmet medical needs. Their AI platform accelerates vaccine target discovery, design, and development.

DR NEERGAARDS VEJ 5F, USA
Näytä profiili